Patient Information EVKEEZA® (ev-kee’-zah) (evinacumab-dgnb) injection, for intravenous use What is EVKEEZA? EVKEEZA is an injectable prescription medicine used along with diet and …

EVKEEZA is an injectable prescription medicine used along with other low-density lipoprotein (LDL) lowering medicines in people 5 years of age and older with a type of high cholesterol …

Sep 29, 2025 · Evkeeza (evinacumab) infusion is used for HoFH in adults and pediatric patients to reduce LDL-cholesterol levels. Includes Evkeeza side effects, dose, and more.

EVKEEZA is an angiopoietin-like 3 (ANGPTL3) inhibitor indicated as an adjunct to other low-density lipoprotein-cholesterol (LDL-C) lowering therapies for the treatment of adult and …

Sep 25, 2025 · Label: EVKEEZA- evinacumab injection, solution, concentrate Label RSS NDC Code (s): 61755-010-01, 61755-013-01 Packager: Regeneron Pharmaceuticals, Inc. Category: …

ABOUT EVKEEZA ® (evinacumab-dgnb) EVKEEZA is the first and only FDA-approved ANGPTL3 inhibitor for lowering LDL-C and other lipoproteins independently of LDL-receptor activity1,2

Nov 30, 2022 · Evkeeza was invented using Regeneron's VelocImmune® technology and is a fully human monoclonal antibody that binds to and blocks the function of ANGPTL3, a protein that …

Sep 25, 2025 · Regeneron Pharmaceuticals, Inc.: EVKEEZA is indicated as an adjunct to diet and exercise and other low-density lipoprotein-cholesterol (LDL-C) lowering therapies to reduce LDL …

Learn how adding EVKEEZA® to other bad cholesterol (LDL-C)–lowering treatments can help people living with HoFH. See Important Safety Information & PI on site.

Dec 21, 2020 · Dosing & Administration EVKEEZA is a 60-minute, once-monthly infusion 1 Recommended dosage The recommended dosage of EVKEEZA is 15 mg/kg administered by IV …